Both mutational changes (expression of the Pax3::Foxo1 fusion protein) and cell of origin (specific myogenic lineage in which the tumour developed) were identified as important factors contributing to the DNA methylation pattern of these tumours. This evidence concerns the gene PAX3 and neoplasm.